Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Hope for better drugs to treat stroke and heart attacks

02.05.2014

An international team of researchers in cooperation with the University of Bonn has taken two "snapshots" of a receptor which are of critical importance for blood coagulation.

The scientists now hope to be able to develop novel drugs using these results. These include tailor-made blood-thinning substances for heart attack and stroke patients whose effects are reversible and better controllable than those of current therapies. The researchers are presenting their results in the renowned journal "Nature."


Crystal structure and function of the P2Y12 receptor: The receptor is shown as a yellow ribbon (bottom).

(c) Graphic: Katya Kadyshevskaya/Stevens Laboratory/The Scripps Research Institute

After a cut to the finger, blood platelets come into play: they adhere to one another and thus close the wound. The adenosine diphosphate receptor P2Y12, found on the surface of platelets, plays an important role in this essential mechanism. It belongs to the family of so-called G-protein-coupled receptors (GPCR); two American researchers were awarded the Nobel prize in 2012 for research involving these receptors.

"If adenosine diphosphate (ADP) binds to the receptor, signals are transmitted to the inside of the cell which will finally lead to platelet aggregation," said Prof. Dr. Christa Müller from the Pharma-Center of the University of Bonn. In this process, the receptor and its binding partner ADP fit together precisely like a lock and a key. "The ADP can be thought of as a key which unlocks the receptor (the “lock”) to allow the signal for platelet aggregation to pass," explains the pharmacist.

... more about:
»ADP »Nature »adenosine »attack »blood »drugs »receptor »snapshots »stroke

Better control through a reversible blockade

However, platelet aggregation is sometimes undesired. For example, in the case of a heart attack or a stroke aggregated platelets occlude important blood vessels. As a preventive medicine blood thinners are generally prescribed to such patients, in order to prohibit further damage due to occluded blood vessels.

Pills containing the drug clopidogrel, that must be initially activated in the liver, are of great importance, since it blocks the P2Y12 receptor and thus prevents platelet aggregation. Since clopidogrel is an irreversible inhibitor, only with the formation of new platelets after approximately one to two weeks, this effect subsides in the patients.

"An effective, direct, reversible blockade of the receptor would be desirable to be able to better control aggregation and prevent overdose," said Prof. Müller. Also, if a patient treated with clopidogrel meets with an accident, a drug which can quickly detach from the receptor would be advantageous. This would prevent the injured patient from hemorrhaging due to the previously administered blood thinner. Such drugs are being developed, but so far all of them appear to show unwanted side-effects.

Two "snapshots" show the mode of operation of the receptor

"To date, it has not been understood well how exactly the receptor works according to the lock-and-key principle," stated Prof. Müller. "However, this is an important precondition for developing such a reversible, highly effective and, at the same time well tolerated drug with few adverse effects, for the prevention of platelet aggregation."

In an international team under the direction of Chinese colleagues from Shanghai and together with US researchers from Bethesda and La Jolla, the pharmacist was able to take two "snapshots" of the receptor with the help of X-ray structural analysis: once in the "unlocked" state, when a suitable binding partner ensures signal transmission in the platelet. The other shot shows the P2Y12 receptor in the blocked – "locked" – state. This shot has recently been published online in a "Nature" publication.

Both publications will appear in the printed edition of "Nature" in direct succession. "Using these two images, we can now envisage how the receptor protein’s conformation is changed during unlocking," said Prof. Müller. This knowledge will also allow the design of new drugs, which selectively and reversibly block the receptor.

"However, further intensive research is needed until such new drugs will come onto the market," said the pharmacist from the University of Bonn. Since there are many receptors with very similar properties, the research into the P2Y12 receptor gives hope for other applications. Thus the related P2Y2 receptor is, for example, involved in the metastasis of tumor cells. "Here, too, new options for cancer research could arise," said the pharmacist with an optimistic view towards the future.

Publications
Agonist-bound structure of the human P2Y12 receptor, journal "Nature", DOI: 10.1038/nature13288
Structure of the human P2Y12 receptor in complex with an antithrombotic drug, journal "Nature", DOI: 10.1038/nature13083

Contact information:

Prof. Dr. Christa E. Müller
Pharmaceutical Institute
of the University of Bonn
Tel. 0228/732301
E-Mail: christa.mueller@uni-bonn.de

Johannes Seiler | idw - Informationsdienst Wissenschaft
Further information:
http://www.uni-bonn.de/

Further reports about: ADP Nature adenosine attack blood drugs receptor snapshots stroke

More articles from Health and Medicine:

nachricht New leukemia treatment offers hope
23.09.2016 | King Abdullah University of Science and Technology

nachricht Alzheimer’s: Cellular Mechanism Provides Explanation Model for Declining Memory Performance
21.09.2016 | Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE)

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: OLED microdisplays in data glasses for improved human-machine interaction

The Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP has been developing various applications for OLED microdisplays based on organic semiconductors. By integrating the capabilities of an image sensor directly into the microdisplay, eye movements can be recorded by the smart glasses and utilized for guidance and control functions, as one example. The new design will be debuted at Augmented World Expo Europe (AWE) in Berlin at Booth B25, October 18th – 19th.

“Augmented-reality” and “wearables” have become terms we encounter almost daily. Both can make daily life a little simpler and provide valuable assistance for...

Im Focus: Artificial Intelligence Helps in the Discovery of New Materials

With the help of artificial intelligence, chemists from the University of Basel in Switzerland have computed the characteristics of about two million crystals made up of four chemical elements. The researchers were able to identify 90 previously unknown thermodynamically stable crystals that can be regarded as new materials. They report on their findings in the scientific journal Physical Review Letters.

Elpasolite is a glassy, transparent, shiny and soft mineral with a cubic crystal structure. First discovered in El Paso County (Colorado, USA), it can also be...

Im Focus: Complex hardmetal tools out of the 3D printer

For the first time, Fraunhofer IKTS shows additively manufactured hardmetal tools at WorldPM 2016 in Hamburg. Mechanical, chemical as well as a high heat resistance and extreme hardness are required from tools that are used in mechanical and automotive engineering or in plastics and building materials industry. Researchers at the Fraunhofer Institute for Ceramic Technologies and Systems IKTS in Dresden managed the production of complex hardmetal tools via 3D printing in a quality that are in no way inferior to conventionally produced high-performance tools.

Fraunhofer IKTS counts decades of proven expertise in the development of hardmetals. To date, reliable cutting, drilling, pressing and stamping tools made of...

Im Focus: Launch of New Industry Working Group for Process Control in Laser Material Processing

At AKL’16, the International Laser Technology Congress held in May this year, interest in the topic of process control was greater than expected. Appropriately, the event was also used to launch the Industry Working Group for Process Control in Laser Material Processing. The group provides a forum for representatives from industry and research to initiate pre-competitive projects and discuss issues such as standards, potential cost savings and feasibility.

In the age of industry 4.0, laser technology is firmly established within manufacturing. A wide variety of laser techniques – from USP ablation and additive...

Im Focus: New laser joining technologies at ‘K 2016’ trade fair

Every three years, the plastics industry gathers at K, the international trade fair for plastics and rubber in Düsseldorf. The Fraunhofer Institute for Laser Technology ILT will also be attending again and presenting many innovative technologies, such as for joining plastics and metals using ultrashort pulse lasers. From October 19 to 26, you can find the Fraunhofer ILT at the joint Fraunhofer booth SC01 in Hall 7.

K is the world’s largest trade fair for the plastics and rubber industry. As in previous years, the organizers are expecting 3,000 exhibitors and more than...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Experts from industry and academia discuss the future mobile telecommunications standard 5G

23.09.2016 | Event News

ICPE in Graz for the seventh time

20.09.2016 | Event News

Using mathematical models to understand our brain

16.09.2016 | Event News

 
Latest News

Chains of nanogold – forged with atomic precision

23.09.2016 | Life Sciences

New leukemia treatment offers hope

23.09.2016 | Health and Medicine

Self-assembled nanostructures hit their target

23.09.2016 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>